Amicus Therapeutics (Nasdaq: FOLD) plans to submit a Japanese new drug application (J-NDA) to request marketing authorization for migalastat, an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE